NCT05271747View on ClinicalTrials.gov

Prospective Study to Determine the Factors Influencing Infant Colic

NACompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions

Infant Colic

Interventions

DIETARY_SUPPLEMENT

AB-Kolicare

Probiotic multi-strain formulation containing Bifidobacterium longum CECT7894 and Pediococcus pentosaceus CECT8830 for 21 days, 5 drops/day preferably during the first intake of milk

DIETARY_SUPPLEMENT

Reuteri gotas

Probiotic single-strain formulation containing Lactobacillus reuteri DSM17938 for 21 days, 5 drops/day before or after any daily meal.

Trial Locations (4)

14050

Hospital Medica Sur, room 108, tower 2, Mexico City

30202

University Hospital Santa Lucía, Cartagena

Unknown

HM Hospitals, Barcelona

Hm Hospitals, Madrid

All Listed Sponsors

lead

AB Biotics, SA

INDUSTRY

NCT05271747 - Prospective Study to Determine the Factors Influencing Infant Colic | Biotech Hunter | Biotech Hunter